Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/bcp.12208 http://scihub22266oqcxt.onion/10.1111/bcp.12208 C3971979!3971979 !23834499     free     free     free       Br+J+Clin+Pharmacol 2014 ; 77 (4 ): 618-25 Nephropedia Template TP {{tp|p=23834499 |t=2014. The genetics of pro-arrhythmic adverse drug reactions |pdf=|usr=}}{{23834499 }} gab.com Text The genetics of pro-arrhythmic adverse drug reactions JO: Br J Clin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=23834499 #FOAvip Ventricular arrhythmia induced by drugs (pro-arrythmia) is an uncommon event, whose occurrence is unpredictable but potentially fatal. The ability of a variety of medications to induce these arrhythmias is a significant problem facing the pharmaceutical industry. Genetic variants have been shown to play a role in adverse events and are also known to influence an individual's optimal drug dose. This review provides an overview of the current understanding of the role of genetic variants in modulating the risk of drug induced arrhythmias. Twit Text FOAVip The genetics of pro-arrhythmic adverse drug reactions ????Br J Clin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=23834499 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=23834499 #FOAvip English Wikipedia <ref>{{Cite pmid|23834499 }}</ref> The genetics of pro-arrhythmic adverse drug reactions #MMPMID23834499 Petropoulou E ; Jamshidi Y ; Behr ER Br J Clin Pharmacol 2014[Apr]; 77 (4 ): 618-25 PMID23834499 show ga Ventricular arrhythmia induced by drugs (pro-arrythmia) is an uncommon event, whose occurrence is unpredictable but potentially fatal. The ability of a variety of medications to induce these arrhythmias is a significant problem facing the pharmaceutical industry. Genetic variants have been shown to play a role in adverse events and are also known to influence an individual's optimal drug dose. This review provides an overview of the current understanding of the role of genetic variants in modulating the risk of drug induced arrhythmias. |*Genetic Variation [MESH] |Anti-Arrhythmia Agents/*adverse effects [MESH] |Arrhythmias, Cardiac/chemically induced/*genetics [MESH] |Genome-Wide Association Study [MESH] |Humans [MESH] |Inactivation, Metabolic/genetics [MESH] |Long QT Syndrome/chemically induced/*genetics [MESH] |Risk Factors [MESH]The genetics of pro-arrhythmic adverse drug reactions (epmc).pdf DeepDyve Pubget Overpricing